NFTC
ABBV icon

North Forty Two & Co’s AbbVie ABBV Stock Holding History

North Forty Two & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$645K Hold
2,564
– – 0.55% 51
2026
Q1 		$558K Hold
2,564
– – 0.52% 52
2025
Q4 		$586K Hold
2,564
– – 0.55% 49
2025
Q3 		$594K Hold
2,564
– – 0.58% 50
2025
Q2 		$476K Sell
2,564
-35
-1% -$6.5K 0.51% 57
2025
Q1 		$545K Buy
2,599
+1
+0% +$194 0.6% 49
2024
Q4 		$462K Buy
+2,598
New +$478K 0.53% 56

Other funds holding ABBV

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

North Forty Two & Co's ABBV Position: Q2 2026 in Review

North Forty Two & Co held its AbbVie (ABBV) position steady in Q2 2026 at 2,564 shares worth $645K. The position accounts for 0.55% of the portfolio, ranked #51.

North Forty Two & Co first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • North Forty Two & Co held 2,564 shares of AbbVie worth $645K as of Q2 2026.
  • North Forty Two & Co left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.55% of North Forty Two & Co's portfolio in Q2 2026, its #51 holding.
  • North Forty Two & Co first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on North Forty Two & Co's 13F filing for Q2 2026, filed 24 Jul 2026.